Detalles de la búsqueda
1.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
N Engl J Med
; 389(20): 1851-1861, 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870969
2.
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.
N Engl J Med
; 389(20): 1839-1850, 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870973
3.
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.
Lancet Oncol
; 23(10): 1261-1273, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108661
4.
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer.
Future Oncol
; 17(7): 763-773, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150799
5.
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
JAMA
; 323(13): 1266-1276, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32259228
6.
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Lancet Oncol
; 16(3): 328-37, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25701171
7.
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.
J Clin Oncol
; 41(2): 385-394, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36122315
8.
Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of life.
BMC Cancer
; 12: 14, 2012 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22244076
9.
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial.
Rare Tumors
; 14: 20363613221100033, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35547106
10.
Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001.
J Thorac Oncol
; 17(6): 768-778, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183775
11.
Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia.
Eur Child Adolesc Psychiatry
; 19(1): 57-66, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19568826
12.
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer.
Lung Cancer
; 137: 136-143, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31586771
13.
Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG).
Breast Cancer Res Treat
; 112(3): 557-63, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18189160
14.
First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis.
J Thorac Dis
; 10(12): 6677-6694, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30746213
15.
Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
Thromb Res
; 167: 50-56, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29787943
16.
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study.
Cancer Res Treat
; 49(4): 937-946, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28111429
17.
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial.
J Clin Oncol
; 23(7): 1401-8, 2005 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15735116
18.
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.
Lung Cancer
; 52(2): 155-63, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16569462
19.
Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial.
Eur Neuropsychopharmacol
; 16(5): 340-9, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16356696
20.
Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE).
Oncol Res Treat
; 39(9): 539-47, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27614872